先端ロボット・内視鏡手術学

Medicine & Life Sciences

1. Gastrectomy 100%
2. Stomach Neoplasms 74%
3. Robotics 51%
4. Stomach 37%
5. Lymph Node Excision 36%
6. Rectal Neoplasms 29%
7. Laparoscopy 27%
8. Esophagectomy 25%
9. Orotate Phosphoribosyltransferase 21%
10. Japan 21%
11. Carcinoma 21%
12. Neoplasms 21%
13. Recurrence 17%
14. Dissection 16%
15. Drug Therapy 15%
16. Neoplasm Metastasis 15%
17. Pancreatectomy 14%
18. Liver 14%
19. Lymph Nodes 13%
20. Pancreaticoduodenectomy 13%
21. Gastrointestinal Stromal Tumors 12%
22. Hepatic Veins 12%
23. Colorectal Neoplasms 11%
24. Surgeons 11%
25. Retrospective Studies 10%
26. Minimally Invasive Surgical Procedures 10%
27. Chemoradiotherapy 10%
28. Cohort Studies 10%
29. Fluorouracil 9%
30. Capsules 8%
31. Esophageal Neoplasms 8%
32. Dihydrouracil Dehydrogenase (NADP) 8%
33. Operative Time 8%
34. Postoperative Complications 8%
35. Propensity Score 8%
36. Morbidity 8%
37. Thymidylate Synthase 7%
38. Gastroenterostomy 7%
39. Esophageal Squamous Cell Carcinoma 7%
40. Colonic Neoplasms 6%
41. Abdomen 6%
42. Esophagus 6%
43. Vocal Cord Paralysis 6%
44. Therapeutics 6%
45. Margins of Excision 6%
46. Arteries 6%
47. Rectum 6%
48. Prone Position 6%
49. Pancreatic Fistula 6%
50. Pancreaticojejunostomy 6%
51. Prolapse 6%
52. Survival Rate 6%
53. Pancreatic Neoplasms 6%
54. Cisplatin 5%
55. Multicenter Studies 5%
56. Adjuvant Chemotherapy 5%
57. Imatinib Mesylate 5%
58. Anastomotic Leak 5%
59. Colostomy 5%
60. Survival 5%
61. Small Intestine 5%
62. Adenocarcinoma 5%
63. Hepatectomy 5%
64. Gastric Bypass 5%
65. Paclitaxel 5%
66. Rectocele 5%
67. Colectomy 5%
68. Pancreas 5%